Novartis Investigative Site

*See Various Dept.'s*, Arizona

0 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation — Completed
• NVA237 BID Versus Placebo Twelve-week Efficacy Study — Completed
• NVA237 Versus Placebo 12-week Efficacy Study — Completed